Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Retinoic acid (RA) modulates transcription of numerous target genes, thereby regulating a myriad of biological processes. It is well established that RA functions by activating retinoic acid receptors (RARs), which, in turn, control cell differentiation, proliferation, and apoptosis. However, perplexing reports of diverse and sometime opposing actions of RA have been published. Hence, while RA induces apoptosis and inhibits cell growth in some settings, it potentiates proliferation and acts as an anti-apoptotic agent in others. These observations raise the possibility that signaling pathways other than RAR may be involved in mediating RA activities. Here we show that RA is a high affinity ligand for another nuclear receptor, namely the orphan receptor peroxisome proliferator-activated receptor (PPAR) beta/delta. We demonstrate that while RA does not activate PPARalpha and PPARgamma, it binds to PPARbeta/delta with nanomolar affinity, modulates the conformation of the receptor, promotes interaction with the coactivator SRC-1, and efficiently activates PPARbeta/delta-mediated transcription. Transcriptional signaling by RA is thus exerted by a dual pathway, providing a rationale for understanding divergent cellular responses to this hormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80467-0 · Cited by 1,169
The Retinoids-Biology, Chemistry and Medicine
Wolf, G. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.5.796a · Cited by 998
A canonical structure for the ligand-binding domain of nuclear receptors
Wurtz, J.-M., Bourguet, W., Renaud, J.-P., Vivat, V., Chambon, P., Moras, D., & Gronemeyer, H. (1996) · Nature Structural Biology · doi:10.1038/nsb0196-87 · Cited by 985
Retinoids in Embryonal Development
Ross, S. A., McCaffery, P. J., Drager, U. C., & De Luca, L. M. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1021 · Cited by 866
Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliewer, S. A., Willson, T. M., & Xu, H. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80448-7 · Cited by 574
Breitman, T., Collins, S., & Keene, B. (1981) · Blood · doi:10.1182/blood.v57.6.1000.1000 · Cited by 571
Tan, N.-S., Shaw, N. S., Vinckenbosch, N., Liu, P., Yasmin, R., Desvergne, B., Wahli, W., & Noy, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5114-5127.2002 · Cited by 499
Self-citationRetinoids in cancer chemoprevention
Lotan, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801164 · Cited by 423
Research works printed but not linked: 8
- Raffo, P., Emionite, L., Colucci, L., Belmondo, F., Moro, M. G., Bollag, W., and Toma, S. (2000) Anticancer Res. 20, 1535-1543
- Desvergne, B., and Wahli, W. (1999) Endocr. Rev. 20, 649 -688
- Seewaldt, V. L., Johnson, B. S., Parker, M. B., Collins, S. J., and Swisshelm, K. (1995) Cell Growth Differ. 6, 1077-1088
- Lee, H. Y., Dawson, M. I., Walsh, G. L., Nesbitt, J. C., Eckert, R. L., Fuchs, E., Hong, W. K., Lotan, R., and Kurie, J. M. (1996) Cell Growth Differ. 7, 997-1004
- Yen, A., Roberson, M. S., Varvayanis, S., and Lee, A. T. (1998) Cancer Res. 58, 3163-3172
- Wightman, J., Roberson, M. S., Lamkin, T. J., Varvayanis, S., and Yen, A. (2002) Mol. Cancer Ther. 1, 493-506
- Jinno, H., Steiner, M. G., Nason-Burchenal, K., Osborne, M. P., and Telang, N. T. (2002) Int. J. Oncol. 21, 127-134
- Sapi, E., Flick, M. B., Tartaro, K., Kim, S., Rakhlin, Y., Rodov, S., and Kacinski, B. M. (1999) Cancer Res. 59, 5578 -5585
Cited by
Items 101–200 of 244
Orphan Nuclear Receptors as Targets for Drug Development
Mukherjee, S., & Mani, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0117-7 · Cited by 47
“But it was also found to bind to PPARβ/ δ with nanomolar affinity, modulating the conformation of the receptor, promoting interaction with the coactivator SRC1, and efficiently activating PPARβ/ δ-mediated transcription, leading to activation of growth promoting and antiapoptotic pathways.”
InfluentialChen, G. (2021) · Cells · doi:10.3390/cells10082160 · Cited by 49
“In addition to RARs and RXRs [51,52], hepatocyte nuclear factor 4α (HNF4α) [53], chicken ovalbumin upstream promoter-transcription factor II (COUPTFII) [54], and peroxisome proliferator-activated receptor β/δ (PPAR β/δ) [55] have been reported to contribute to RA signaling [56].”
BackgroundPPAR‐δ in Vascular Pathophysiology
Wang, N. (2008) · PPAR Research · doi:10.1155/2008/164163 · Cited by 40
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases
Bedu, E., Wahli, W., & Desvergne, B. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.861 · Cited by 46
Re-adaption on Earth after Spaceflights Affects the Mouse Liver Proteome
Anselm, V., Novikova, S., & Zgoda, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081763 · Cited by 38
“Retinoic acids are mobilized in hepatic stellate cells as part of retinol metabolism [14] and act as upstream PPAR activators [15,16].”
BackgroundCoyle, K. M., Maxwell, S. P., Thomas, M. L., & Marcato, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-16687-6 · Cited by 40
Alessandri, J., Extier, A., Al-Gubory, K. H., Goustard, B., Baudry, C., LePoupon, C., Lavialle, M., & Guesnet, P. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.07.005 · Cited by 41
“has been shown in cell models that retinoic acid is a high affinity ligand of both PPARδ and RARα (both functioning as a heterodimer with RXR) suggesting that, in some tissues, retinoic acidsmay activate transcription of target genes not only through RARα but also through PPARδ [27–29].”
BackgroundChen, J., Costa, L. G., & Guizzetti, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182196 · Cited by 39
“Retinoids also exert biological effects that are independent of activation of RXR and RAR; for example, tretinoin activates the peroxisome proliferator-activator receptors / (Shaw et al., 2003; Schug et al., 2007), and several retinoids modulate protein kinase C and cAMP response element-binding protein activity with…”
BackgroundHepatic retinoid stores are required for normal liver regeneration
Shmarakov, I. O., Jiang, H., Yang, K. J. Z., Goldberg, I. J., & Blaner, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m029801 · Cited by 35
Wolf, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00261.x · Cited by 35
Lim, H. J., Moon, I., & Han, K. (2004) · Endocrinology · doi:10.1210/en.2004-0011 · Cited by 40
Ligand binding pocket function of Drosophila USP is necessary for metamorphosis
Jones, G., Teal, P. E. A., Henrich, V. C., Krzywonos‐Zawadzka, A., Sapa-Wojciechowska, A., Woźniak, M., Smolka, J. A., & Jones, D. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.11.009 · Cited by 36
Zile, M. H. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900703 · Cited by 34
“Furthermore, elucidation of the function of the recently identified retinoic acid–specific receptor PPARb/d (18) will undoubtedly fill in some gaps regarding the function of retinoic acid during development.”
BackgroundInfluentialRetinoid Signaling in Cancer and Its Promise for Therapy
Coyle, K. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s7-006 · Cited by 36
“Binding to FABP5 delivers RA to PPARβ/δ isoforms instead of to RARs (Figure 3B) [95,97,98].”
BackgroundControl of Innate and Adaptive Lymphocytes by the RAR-Retinoic Acid Axis
Kim, C. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e1 · Cited by 34
Coll, T., Barroso, E., Álvarez-Guardia, D., Serrano, L., Salvadó, L., Merlos, M., Palomer, X., & Vázquez‐Carrera, M. (2010) · PPAR Research · doi:10.1155/2010/368467 · Cited by 38
Gopal, K., Nagarajan, P., Jedy, J., Raj, A. T., Kalai Gnanaselvi, S., Jahan, P., Sharma, Y., Shankar, E. M., & Kumar, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067098 · Cited by 32
“RA does not activate PPAR-a and PPAR-c but, apocarotenals repress PPAR and RXR activation [30,32].”
BackgroundZaitseva, M., Vollenhoven, B., & Rogers, P. A. W. (2008) · Human Reproduction · doi:10.1093/humrep/den083 · Cited by 34
“Conversion of dietary retinol to RA is controlled by complex interactions and bioavailability of binding proteins, and several families of metabolic enzymes (Duester, 2000; Duester et al., 2003; Shaw et al., 2003; Schug et al., 2007).”
BackgroundThe link between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease
Chen, G. (2015) · Current Drug Targets · doi:10.2174/1389450116666150325231015 · Cited by 33
Everts, H. B., King, L. E., Sundberg, J. P., & Ong, D. E. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23223.x · Cited by 32
“Also, RA has been found to activate PPAR b/d (Shaw et al, 2003), whereas the drug, clofibrate, has been found to increase barrier function (Hanley et al, 1999).”
BackgroundKhorasani, A., Abbasnejad, M., & Esmaeili‐Mahani, S. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1634067 · Cited by 34
Fauti, T., Müller‐Brüsselbach, S., Kreutzer, M., Rieck, M., Meißner, W., Rapp, U. R., Schweer, H., Kömhoff, M., & Müller, R. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.05055.x · Cited by 28
Berry (2007) · doi:10.1155/2007/73256 · Cited by 28
“Nevertheless, RA enhances the ability of PPARβ/δ, but not other PPAR isotypes, to induce the expression of a reporter gene driven by a PPRE [34], suggesting that it functions as a selective PPARβ/δ ligand.”
BackgroundMarwarha, G., Berry, D. C., Croniger, C. M., & Noy, N. (2013) · The FASEB Journal · doi:10.1096/fj.13-234310 · Cited by 30
Self-citationCell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma
Bell, E., Ponthan, F., Whitworth, C., Westermann, F., Thomas, H. D., & Redfern, C. P. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068859 · Cited by 29
“Although previous studies have suggested that ATRA is a potent PPARd ligand [13], subsequent work has not been able to demonstrate binding of ATRA to PPARd, PPREreporter activation by 0.”
BackgroundInfluentialVitamin A–Not for Your Eyes Only: Requirement for Heart Formation Begins Early in Embryogenesis
Zile, M. H. (2010) · Nutrients · doi:10.3390/nu2050532 · Cited by 32
RETRACTION: All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver
Tripathy, S., Chapman, J. D., Han, C. Y., Hogarth, C. A., Arnold, S. L. M., Onken, J. L., Kent, T., Goodlett, D. R., & Isoherranen, N. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.103697 · Cited by 30
“, 2012), but atRA also activates the peroxisome proliferator-activated receptor (PPAR)-b/d (Shaw et al., 2003; Berry and Noy, 2007; Wolf, 2010).”
BackgroundRetractedPotential role of retinoids in ovarian physiology and pathogenesis of polycystic ovary syndrome
Jiang, Y., Li, C., Chen, L., Wang, F., & Zhou, X. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.03.025 · Cited by 31
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma
Xu, Y., Li, X., Han, Y., Wang, Z., Han, C., Ruan, N., Li, J., Yu, X., Xia, Q., & Wu, G. (2020) · PPAR Research · doi:10.1155/2020/6937475 · Cited by 28
CYP4A11 is repressed by retinoic acid in human liver cells
Antoun, J., Amet, Y., Simon, B., Dréano, Y., Corlu, A., Corcos, L., Salaun, J. P., & Plée‐Gautier, E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.006 · Cited by 26
“The high affinity of retinoids for PPARb and their ability to mediate transcription [31] also led us to investigate the effect of L-165,041, a PPARb selective agonist, on CYP4A11 gene expression.”
BackgroundThe Transcriptional Role of Vitamin A and the Retinoid Axis in Brown Fat Function
Herz, C. T., & Kiefer, F. W. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00608 · Cited by 28
“PPARδ is another nuclear receptor regulated by all-trans retinoic acid with the potential to regulate BAT activity (43).”
BackgroundLucas, R., Mihály, J., Lowe, G. M., Graham, D. L., Szklenár, M., Szegedi, A., Törőcsik, D., & Rühl, R. (2018) · Nutrients · doi:10.3390/nu10101390 · Cited by 27
Retinoic Acid Receptor Subtype-Specific Transcriptotypes in the Early Zebrafish Embryo
Samarut, É., Gaudin, C., Hughes, S., Gillet, B., de Bernard, S., Jouve, P.-E., Buffat, L., Allot, A., Lecompte, O., Berekelya, L., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1358 · Cited by 33
Wang, L., Tang, Y., Rubin, D. C., & Levin, M. S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00567.2006 · Cited by 24
“The prosurvival effects of RA could also occur by this mechanism, since RA has been identified as a potent ligand for PPAR / (46).”
BackgroundRoles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance
Chen, G. (2013) · ISRN Hepatology · doi:10.1155/2013/534972 · Cited by 27
“Other metabolic signals in combination with RA may affect the occupancy of the nuclear receptors bound to the RARE and their activations and may, in turn, alter the outcomes of the RA-mediated transcription responses.”
BackgroundWu, L., Chaudhary, S. C., Atigadda, V. R., Belyaeva, O. V., Harville, S. R., Elmets, C. A., Muccio, D. D., Athar, M., & Kedishvili, N. Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153556 · Cited by 27
“It has been reported that ATRA can bind not only to RARs but also to PPARδ, albeit with a higher Kd value than to RAR [57], and that the ratio between cellular retinoic acid binding protein type II (CRABP-II) and fatty acid binding protein type 5 (FABP5), the two carrier proteins which deliver ATRA to RAR and PPARδ, r…”
BackgroundLétondor, A., Buaud, B., Vaysse, C., Richard, E., Layé, S., Pallet, V., & Alfos, S. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00103 · Cited by 30
Weindl, G., fer-Korting, M. S., Schaller, M., & Körting, H. C. (2005) · Drugs · doi:10.2165/00003495-200565140-00002 · Cited by 29
Zhang, Y., Xiao, B., Liu, Y., Wu, S., Xiang, Q., Xiao, Y., Zhao, J., Yuan, R., Xie, K., & Li, L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176304 · Cited by 24
Muscle-UCP3 in the regulation of energy metabolism
Guardia, L. D., Luzi, L., & Codella, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101872 · Cited by 26
Parodi, P. W. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2015.12.028 · Cited by 25
Kim, J., Wellmann, K. B., Smith, Z. K. F., & Johnson, B. J. (2018) · Journal of Animal Science · doi:10.1093/jas/sky155 · Cited by 25
Sharma, P., Gill, N., & Bijjem, K. R. V. (2013) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.111944 · Cited by 24
“[25-27] Thus, in the present study the observed anti-inflammatory and anti-hyperalgesic effect of GW0742 may be due to activation of PPAR-β/δ. ATRA, the most active metabolite of vitamin A, has been shown to regulate a wide range of biological processes; such as cell proliferation, differentiation, morphogenesis, and…”
BackgroundMethodInfluentialRoles of peroxisome proliferator-activated receptor ?? in skeletal muscle function and adaptation
Fredenrich, A., & Grimaldi, P. A. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134370.93686.0a · Cited by 28
Non-classical Transcriptional Activity of Retinoic Acid
Noy, N. (2016) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-024-0945-1_7 · Cited by 23
Self-citationXu, M., Zhou, F., Ahmed, O., Upadhya, G. A., Jia, J., Lee, C., Xing, J., Li, Y., Shim, S. H., Zhang, Z., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003675 · Cited by 20
Thymus vulgaris Essential Oil in Beta-Cyclodextrin for Solid-State Pharmaceutical Applications
Arrais, A., Bona, E., Todeschini, V., Caramaschi, A., Massa, N., Roncoli, M., Minervi, A., Perin, E., & Gianotti, V. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030914 · Cited by 19
Signaling by retinol and its serum binding protein
Noy, N. (2014) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2014.10.004 · Cited by 21
“1), which regulates gene transcription by activating several members of the nuclear receptor family of ligand-controlled transcription factors [4–7].”
BackgroundSelf-citationRaldh1 promotes adiposity during adolescence independently of retinal signaling
Yang, D., Krois, C. R., Huang, P., Wang, J., Min, J., Yoo, H. S., Deng, Y., & Napoli, J. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187669 · Cited by 19
Retinoic Acid-mediated Nuclear Receptor Activation and Hepatocyte Proliferation
Bushue, N., & Wan, Y. Y. (2009) · Journal of Experimental & Clinical Medicine · doi:10.1016/s1878-3317(09)60007-3 · Cited by 18
Almaguer, J., Hindle, A., & Lawrence, J. J. (2023) · Antioxidants · doi:10.3390/antiox12111921 · Cited by 23
CRABP2 and FABP5 expression levels in diseased and normal pancreas
Hughes, C. S., Chin‐Aleong, J., & Kocher, H. M. (2020) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2020.151557 · Cited by 18
Drosophila fabp is required for light-dependent Rhodopsin-1 clearance and photoreceptor survival
Huang, H.-W., & Ryoo, H. D. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009551 · Cited by 17
“The human homologs of fabp are known to bind all trans RA with high affinity [35,36,46,47].”
Mollashahi, M., Abbasnejad, M., & Esmaeili‐Mahani, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.05.013 · Cited by 18
Peroxisome Proliferator-Activated Receptors Features, Functions, and Future
Youssef, J., & Badr, M. Z. (2015) · Nuclear Receptor Research · doi:10.11131/2015/101188 · Cited by 18
“In addition, experiments have demonstrated that although the vitamin A metabolite all-trans-retinoic acid (RA) binds to PPARα and PPARγ with a low affinity, this compound has a high affinity to PPARβ/δ [192].”
BackgroundRossetti, S., Ren, M., Visconti, N. R., Corlazzoli, F., Gagliostro, V., Somenzi, G., Yao, J. G., Sun, Y., & Sacchi, N. (2016) · Oncotarget · doi:10.18632/oncotarget.13500 · Cited by 16
“Moreover, RA controls other transcriptional signaling pathways via different nuclear receptors, such as peroxisome proliferator-activated receptor β/δ (PPARD) [19, 20] and chicken ovalbumin upstream promoter transcription factor 2 (COUP-TFII) [21].”
BackgroundRetinoids in Cutaneous Squamous Cell Carcinoma
Everts, H. B., & Akuailou, E.-N. (2021) · Nutrients · doi:10.3390/nu13010153 · Cited by 18
Fatty Acid Synthesis and PPARα Hand in Hand
Rotman, N., & Wahli, W. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.08.004 · Cited by 17
“Recently, a few reports have pointed to natural molecules with a nanomolar affinity for PPARs (Davies et al., 2001; Lin et al., 1999; Shaw et al., 2003; Schopfer et al., 2005).”
BackgroundRecent insights on the role and regulation of retinoic acid signaling during epicardial development
Wang, S., & Moise, A. R. (2019) · genesis · doi:10.1002/dvg.23303 · Cited by 17
Chemogenomics for NR1 nuclear hormone receptors
Isigkeit, L., Schallmayer, E., Busch, R., Brunello, L., Menge, A., Elson, L., Müller, S., Knapp, S., Stolz, A., Marschner, J. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49493-6 · Cited by 16
“…’ stargetsubfamilyweredeterminedinuniformhybrid reporter gene assays; n =3; activities outside the subfamilies reported in literature (retinoic acid 76 – 78 , GW7647 79 , SR9009 80 , LXR-623 81 ) were checked and only con-fi rmed for retinoic acid (NR1F) and LXR-623 (NR1I) at the recommended…”
Retinoid chemistry: Synthesis and application for metabolic disease
Curley, R. W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.04.007 · Cited by 14
In utero exposure to bisphenol-A disrupts key elements of retinoid system in male mice offspring
Esteban, J., Serrano‐Maciá, M., Sánchez-Pérez, I., Alonso‐Magdalena, P., Pellín, M. D. L. C., García‐Arévalo, M., Nadal, Á., & Barril, J. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.02.023 · Cited by 14
Kalitin, N. N., & Karamysheva, A. F. (2016) · Cell Biology International · doi:10.1002/cbin.10587 · Cited by 16
“RARa rather than PPARb/d is activated in A549 cells after atRA treatment Taking into account that both RARs and PPARs receptors are suggested to bind atRA, we studied RARa and PPARb/d protein and gene expression in A549 cells before and after addition of different concentrations of atRA.”
BackgroundInfluentialA Role for PPARβ/δ in Ocular Angiogenesis
Bishop‐Bailey, D. (2008) · PPAR Research · doi:10.1155/2008/825970 · Cited by 13
“Retinol is converted to retinaldehyde, a component of rhodopsin [14] and a functional PPARγ antagonist [15, 16], which in turn is metabolised to ATRA by retinal dehydrogenases [14].”
BackgroundInfluentialWestekemper, H., Freistuehler, M., Anastassiou, G., Nareyeck, G., Bornfeld, N., Steuhl, K., Scheulen, M. E., & Hilger, R. A. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300686 · Cited by 12
“In other cellular settings, RA promotes cell survival by interacting with the nuclear receptor PPAR-b/d.(6) For this orphan nuclear receptor, no specific ligand had been reported.”
BackgroundPasseri, D., Doldo, E., Tarquini, C., Costanza, G., Mazzaglia, D., Agostinelli, S., Campione, E., Stefani, A. D., Giunta, A., Bianchi, L., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.01.039 · Cited by 15
PPAR δ : A Potential Therapeutic Target for the Treatment of Metabolic Hypertension
Jiang, Y., Li, Q., Jia, M., & Yan, Z. (2019) · International Journal of Hypertension · doi:10.1155/2019/7809216 · Cited by 11
“that prostacyclin [6] and retinoic acid [7] efficiently activate”
BackgroundRetinoic acid homeostasis and disease
Kane, M. A. (2024) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2024.11.001 · Cited by 14
Vitamin A retinoic acid contributes to muscle stem cell and mitochondrial function loss in old age
Fraczek, P. M., Duran, P., Yang, B. A., Ferre, V., Alawieh, L., Castor‐Macias, J. A., Wong, V. T., Guzman, S. D., Piotto, C., Itsani, K., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.183706 · Cited by 14
“VA metabolites have been shown to interact with the α -subunit of mitochondrial ATP synthase and PPARs, which heterodi-merize with RXRs to activate the oxidoreductase acyl-CoA oxidase (61–63).”
Allergen-Induced Dermatitis Causes Alterations in Cutaneous Retinoid-Mediated Signaling in Mice
Gericke, J., Ittensohn, J., Mihály, J., Dubrac, S., & Rühl, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071244 · Cited by 11
“(Crabp2) initiates RAR signaling, whereas the fatty acid-binding protein 5 (Fabp5) promotes PPARd-mediated signaling after ATRA-binding [19,20].”
BackgroundBMP and RA signaling cooperate to regulate Apolipoprotein C1 expression during embryonic development
Wang, Y., Li, W.-H., Li, Z., Liu, W., Zhou, L., & Gui, J. (2014) · Gene · doi:10.1016/j.gene.2014.10.047 · Cited by 11
“Evidence in mammalian has established that RA acts as a ligand of nuclear receptors (Giguere et al., 1987; Petkovich et al., 1987; Mangelsdorf and Evans, 1995; Shaw et al., 2003),which regulate transcription of awide range of target lipoprotein genes.”
BackgroundGenetic and pathologic aspects of retinoic acid‐induced limb malformations in the mouse
Lee, G. S., Liao, X., Shimizu, H., & Collins, M. D. (2010) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20712 · Cited by 15
Metabolism of Vitamin A in White Adipose Tissue and Obesity
Jeyakumar, S. M., Yasmeen, R., Reichert, B., & Ziouzenkova, O. (2013) · Oxidative stress and disease · doi:10.1201/b14569-4 · Cited by 12
Enzymatic intracrine regulation of white adipose tissue
DiSilvestro, D. J., Petrosino, J. M., Aldoori, A., Melgar-Bermudez, E., Wells, A., & Ziouzenkova, O. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0019 · Cited by 10
“Noa Noy and co-workers showed that all-trans retinoic acid (atRA) can directly bind to PPARd at concentrations higher than 100 nM (Kd = 770 nM) [131].”
BackgroundEvaluation of vitamin A status on myogenic gene expression and muscle fiber characteristics
Wellmann, K. B., Kim, J., Urso, P., Smith, Z. K. F., & Johnson, B. J. (2021) · Journal of Animal Science · doi:10.1093/jas/skab075 · Cited by 10
Inspired by Vitamin a for Anti-Ageing: Searching for Plant-Derived Functional Retinoid Analogues
Sadgrove, N. J., Oblong, J. E., & Simmonds, M. S. J. (2021) · Skin Health and Disease · doi:10.1002/ski2.36 · Cited by 11
“Interestingly, tRA is also an agonist of the PPAR‐β/δ nuclear receptor.(55) It has been reported that in this case the intracellular fatty acid binding protein 5 transports tRA into the nucleus, leading to the PPAR‐β/δ regulated expression of other subsets of genes responsible for homeostasis and the insulin response.”
BackgroundA simple method to screen ligands of peroxisome proliferator-activated receptor δ
Cho, M.-C., Yoon, H.-E., Kang, J.-W., Park, S. W., Yang, Y. D., Hong, J. T., Song, E.-Y., Paik, S., Kim, S., & Yoon, D. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.07.003 · Cited by 10
Abed, K., Foucher, A., Bernard, D., Tancrède‐Bohin, E., & Cavusoglu, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-37750-5 · Cited by 11
Retinoic Acid: Metabolism, Developmental Functions, and Evolution
Carvalho, J. E., & Schubert, M. (2013) · CRC Press eBooks · doi:10.1201/b15313-2 · Cited by 10
Ghatpande, S. K., Zhou, H., Čakstiņa, I., Carlson, C., Rondini, E. A., Romeih, M. H., & Zile, M. H. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01183.x · Cited by 10
“…RARs, and the retinoid- X-receptors, RXRs (Bastien & Rochette-Egly 2004; Dolle 2009; Mark et al. 2009; Rochette-Egly & Germain 2009) and PPAR b ⁄ d (Shaw et al. 2003; Schug et al. 2007; Berry to whom all correspondence should be addressed. ile@anr.msu.edu ed in loving memory to Dr. Anita B.…”
BackgroundRole of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation
Lee, M. Y., Lee, Y. J., Kim, Y. H., Lee, S. H., Park, J. H., Kim, M., Suh, H. N., Ryu, J. M., Yun, S. P., Jang, M. W., et al. (2009) · International Journal of Stem Cells · doi:10.15283/ijsc.2009.2.1.28 · Cited by 9
Velkov, T., Rimmer, K. A., & Headey, S. J. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.09.012 · Cited by 8
Aberrant retinoic acid production in the decidua: Implications for pre‐eclampsia
Rajakumar, A., Kane, M. A., Yu, J., Taylor, R. N., & Sidell, N. (2020) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14262 · Cited by 7
β-Carotene regulates expression of β-carotene 15,15′-monoxygenase in human alveolar epithelial cells
Gong, X., Marisiddaiah, R., & Rubin, L. P. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.09.013 · Cited by 9
Koshiishi, C., Kanazawa, T., Vangrevelinghe, E., Honda, T., & Hatakeyama, S. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02849 · Cited by 8
Nuclear Receptors and the Hidden Language of the Metabolome
Chen, Y., Anderson, M. T., Payne, N., Santori, F. R., & Ivanova, N. B. (2024) · Cells · doi:10.3390/cells13151284 · Cited by 9
“PPARδ also binds retinoic acid with a high affinity [126].”
BackgroundHan, K., Moon, I., & Lim, H. J. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0173-4 · Cited by 8
Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review
Marchwicka, A., Cunningham, A., Marcinkowska, E., & Brown, G. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1205586 · Cited by 7
“Recent observations suggest that, in addition to RARs, the retinoic acid signaling pathway involves the peroxisome proliferator–activated receptor β/δ (PPAR β/δ) [11].”
BackgroundPeroxisome Proliferator-Activated Receptor β/δ: A novel target for the reduction of atherosclerosis
Gross, B. S., Fruchart, J., & Staels, B. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.08.009 · Cited by 8
Evolution of the Retinoic Acid Signaling Pathway
Laudet, V., Zieger, E., & Schubert, M. (2015) · Wiley eBooks · doi:10.1002/9781118628003.ch4 · Cited by 10
Kim, D. S., Itoh, E., Iida, K., & Thorner, M. O. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-219 · Cited by 6
RARγ and TRβ expressions are decreased in PBMC and SWAT of obese subjects in weight gain
Bairras, C., Redonnet, A., Dabadie, H., Gin, H., Atgié, C., Pallet, V., Higueret, P., & Nöel-Suberville, C. (2010) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-010-0006-x · Cited by 6
Hsu, S., Stachon, T., Fries, F. N., Li, Z., Li, S., Liu, S., Seitz, B., Kundu, S., Amini, M., Suiwal, S., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324946 · Cited by 6
“…alpha (RXRA), retinoid X receptor beta (RXRB), fatty acid-binding protein 5 (FABP5), peroxisome proliferator-activated receptor gamma (PPARG), retinoic acid (RA), limbal epethelail cells (LECs). https://doi.org/10.1371/journal.pone.0324946.t005 differentiation is highly context-dependent [32–34].”
InfluentialAlterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications
Muñiz‐Hernández, S., Hernández‐Pedro, N., Macedo-Pérez, O., & Arrieta, O. G. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.68072 · Cited by 5
“Retinoic acid (RA) is the most biologically active isoform; it activates several members of the nuclear receptor family, including the classic retinoic acid receptors (RARs) [4] as well as the peroxisome proliferator-activated receptor β/δ (PPARβ/δ) [5] [6].”
BackgroundLopez-Real, R. E., Budge, J., Marder, T. B., WHITING, A., Hunt, P., & Przyborski, S. A. (2013) · Journal of Anatomy · doi:10.1111/joa.12147 · Cited by 5
“Retinoic acid in keratinocytes is known to be able to promote proliferation via an alternative receptor pathway involving PPARbd and FABP5 (Shaw et al. 2003; Schug et al. 2007).”
Nuclear Receptors, Ligands and the Mammalian B Cell
Jones, B. G., Penkert, R. R., Surman, S. L., Sealy, R. E., & Hurwitz, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144997 · Cited by 5
“Examples include vitamin A metabolites (for RAR, RXR, and the peroxisome proliferator-activated receptor β/δ (PPAR β/δ) [4]), 17-β estradiol (for ER), progesterone (for PR), testosterone and dihydrotestosterone (for AR), 3,3′,5,5′ triiodo-L-thyroxine (for the thyroid receptor [TR]), and dexamethasone and prednisolone…”
BackgroundLucas, R., Mihály, J., Gericke, J., de Lera, Á. R., Álvarez, S., Veleczki, Z., Törőcsik, D., & Rühl, R. (2020) · Dermatology · doi:10.1159/000508334 · Cited by 4
Zhang, X., Paalvast, Y., Wang, Y., Rensen, P. C. N., & Groen, A. K. (2021) · Physiological Reports · doi:10.14814/phy2.14832 · Cited by 4
“Since retinoic acid is also a ligand for the PPAR (Peroxisome Proliferator- Activated Receptor), inhibited vitamin A metabolism is anticipated to reduce the activity of PPAR signaling pathway (Shaw et al., 2003).”
BackgroundLi, S., & Jin, M. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1994-23.2024 · Cited by 3
Ivanova, D. I., Rossin, A., Gronemeyer, H., Valla, A. R., Cartier, D., Guillou, R. L., & Labia, R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.002 · Cited by 3
Metadata
- Authors
- Shaw, N., Elholm, M., & Noy, N.
- Affiliations
- Cornell University (US)
- Corresponding author
- Noy, Noa
- ORCID
- Noy, Noa
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 43
- Pages
- 41589-41592
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2047682339
- Cited by
- 243
- References
- 39
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 7 · 2023: 7 · 2022: 1 · 2021: 9 · 2020: 11 · 2019: 14 · 2018: 7 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 12 · 2013: 21 · 2012: 13
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6206 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK060684)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- retinoic acid, PPARδ, peroxisome proliferator-activated receptors, nuclear receptor ligand binding, orphan nuclear receptor, retinoic acid receptor, PPARα, PPARγ, SRC-1 coactivator, receptor conformational change, transcriptional activation, apoptosis, cell proliferation
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Ligands, Protein Binding, Protein Conformation, Transcription Factors, Transcription, Genetic, Transfection, Tretinoin, Signal Transduction, Titrimetry, Receptors, Cytoplasmic and Nuclear, COS Cells, Histone Acetyltransferases, Nuclear Receptor Coactivator 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.